HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nkondjock, A. Articles by Ghadirian, P. Search for Related Content PubMed PubMed Citation Articles by Nkondjock, A. Articles by Ghadirian, P. Agricola Articles by Nkondjock, A. Articles by Ghadirian, P.

Intake of specific carotenoids and essential fatty acids and breast cancer risk in Montreal, Canada^1,2,3

¹ From the Epidemiology Research Unit, Research Centre, Centre Hospitalier de l’Université de Montréal–Hôtel-Dieu, Montreal (AN and PG), and the McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa (AN).

² Supported by the Canadian Institutes of Health Research, the Montreal Breast Cancer Foundation, and the Fonds de la Recherche en Santé du Québec–Cancer Research Network.

³ Address reprint requests to P Ghadirian, Epidemiology Research Unit, Research Centre, Centre Hospitalier de l’Université de Montréal–Hôtel-Dieu, Pavillon Masson, 3850 Saint Urbain Street, Montreal, Quebec, Canada H2W 1T7. E-mail: parviz.ghadirian{at}umontreal.ca.

	ABSTRACT

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 
Background: Evidence from previous investigations into the possible role of dietary and serum carotenoid concentrations in the etiology of breast cancer is inconsistent. No study has examined the combined effect of carotenoids and essential fatty acids on the risk of breast cancer.

Objective: The objective was to assess the possible association between specific and total carotenoids and breast cancer risk and to evaluate the effect modification by diet-related fatty acids and lifestyle factors in the development of breast cancer.

Design: A population-based case-control study involving 414 incident cases and 429 controls was conducted in French Canadians in Montreal. Dietary intake was estimated with the use of a validated food-frequency questionnaire in face-to-face interviews.

Results: No significant association was apparent between any of the individual or total carotenoids and the risk of breast cancer after adjustment for major underlying determinants of breast cancer. In premenopausal women who ever smoked, an increased risk was related to -carotene [odds ratio (OR) for the upper relative to the lowest quartiles of intake: 2.40; 95% CI: 0.90, 6.41; P for trend = 0.046]. Conversely, a reduced risk was related to ß-carotene (OR: 0.57; 95% CI: 0.26, 1.24; P for trend = 0.05) in women who never used hormone replacement therapy. In postmenopausal women, total carotenoids were positively associated with breast cancer risk in those with a high arachidonic acid intake (OR: 1.92; 95% CI: 0.93, 3.94; P = 0.028 for trend) and inversely associated in those with a high docosahexaenoic acid intake (OR: 0.52; 95% CI: 0.25, 1.07; P for trend = 0.054).

Conclusion: These findings suggest that the combined high intake of total carotenoids and docosahexaenoic acid may reduce the risk of breast cancer.

Key Words: Breast cancer • carotenoids • case-control study • fatty acids • food intake • prevention • French Canadians

	INTRODUCTION

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 
Breast cancer is the second leading cause of cancer-related deaths in women in most industrialized countries. The incidence of this disease in women in Western countries is 5 times that in women in developing countries and Japan (1). In Canada, breast cancer is the most common type of cancer in women, with an age-standardized incidence rate of 103 per 100 000, or 30% of all cancers in women. In 2002, 20 700 new cases and 5400 deaths were attributed to breast cancer (2).

The risk factors for breast cancer include age (3), early menarche (4), late age at menopause (5) and at first full-term pregnancy (3), nulliparity (6), and alcohol consumption (7, 8). Inverse associations with physical activity (7, 9) and breastfeeding (10) have been found.

There is compelling evidence that carotenoids play a role in the etiology of breast cancer. Although research on breast cancer prevention has focused intensively on these micronutrients, the mechanisms involved in their reported cancer-preventing activity are not fully understood (11).

Carotenoids include a large array of substances with different biological properties. Besides their overall influence on enhancement of immune function, cellular protection against DNA damage, stimulation of gap junctions intercellular communication, induction of detoxifying enzymes, and inhibition of cellular proliferation (12, 13), it has been shown that they also have specific activities. -Carotene may decrease the activity of cytochrome P450 1AA, an activator of procarcinogens (14). ß-Carotene is effective in protecting lipid membranes from damage by free radicals and reactive species. Lycopene is the most efficient quencher of singlet oxygen species, lutein and zeaxanthin are scavengers of radical oxygen species (15), and ß-cryptoxanthin may stimulate the expression of RB (an antioncogene) and p73 (a p53-related gene) (16).

Many previous investigations that examined the influence of dietary intake or serum concentrations of carotenoids on the development of breast cancer have yielded mixed results (17-19). Given the inconsistency of findings and continued interest in identifying modifiable risk factors for breast cancer, we carried out a population-based case-control study of specific carotenoids and the risk of breast cancer in French Canadians. French Canadians are a relatively homogeneous population with particular food habits (20), which differentiate them from their neighbors in North America. This investigation also examined the effect modification by diet-related fatty acids, because the antioxidant influence of carotenoids and the susceptibility of these fatty acids to lipid peroxidation suggest interactive biological activities. Finally, we assessed possible associations between breast cancer risk and lifestyle factors, such as smoking, because free radicals in cigarette smoke can alter the concentrations of most carotenoids (21).

	SUBJECTS AND METHODS

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 
Study population
The procedures used to obtain cases and controls for this investigation were described elsewhere (22). Briefly, between 1989 and 1993, all patients aged 35–79 y with a histologic diagnosis of breast cancer were identified through the admission offices of 3 major teaching hospitals of the Réseau Inter-hospitalier de Cancérologie de l’Université de Montréal. When an eligible case was identified, the attending surgeon or physician was approached for permission to interview the patient. If permission was granted, the patient was contacted by letter and followed up with a telephone call to arrange an interview. A total of 935 breast cancer cases were identified, of which 396 (42%) were ineligible for inclusion in the study for various reasons: 62 (7%) because of age, 286 (30%) because they lived outside the study region, 37 (4%) because they had another type of primary cancer or an incorrect diagnosis, and 11 (1%) because they died before the interview. Thus, there were 539 eligible cases, which represented 58% of all cases identified. Of these eligible patients, 72 (13%) refused to participate, 45 could not obtain their doctor’s consent (8%), 6 had a change of address and were unable to be contacted (1%), and 2 had a change in diagnosis (<1%) after the interview. Ultimately, 414 cases were interviewed, which represented a response rate of 77% of eligible cases.

The controls were population-based and matched for age (±5 y in each age group) and place of residence. They were selected from the telephone directory in which the corresponding case was listed and were contacted with the use of a modified, random digit-dialing method. One page from the telephone directory was randomly chosen from the sampling frame, and the names and addresses of 10 persons with the same first 3 digits of the telephone number (of the 7-digit code) were selected for each case. The occupants of these residences were then contacted by telephone to determine whether the household contained someone who matched the index case for age and who agreed to be interviewed. If the telephone was not answered, the telephone number, the date, and the time of the call were recorded, and the same number was called 7 more times during the day, evening, or weekend before the number was rejected. Eligible and willing persons were interviewed at their homes. This procedure was repeated until enough controls were enrolled. If more than one eligible control was reached at a given number, this information was kept in a database for future use. All controls were interviewed within 3 mo after the matching cases were interviewed. This study was conducted in parallel with a similar investigation of colon and prostate cancer, and a common control population was selected. A total of 2085 controls were selected, of whom only 1361 (65%) fulfilled the eligibility criteria. A total of 171 (8%) household residents never answered the telephone, 335 (16%) refused to participate before the study was explained to them, and 167 (8%) refused to participate after the study was explained to them. Thus, a total of 668 subjects were interviewed, 429 of whom were women.

Data collection
For both cases and controls, interviews were conducted in the respondent’s home with the use of structured questionnaires administered in a standardized manner. If either the case or the control was hospitalized at the time of the scheduled interview and seemed unlikely to be available for home interview within 2 wk, an in-hospital interview was arranged. If the patient was very ill, whether at home or in the hospital, the interview was carried out in the presence and with the help of any family member or other person who was available and likely to have relevant information. No proxy interviews were performed. The core questionnaire collected data on lifestyle, occupation, education, drinking and smoking habits, medical history, history of weight changes, and family history of cancer.

Food intake
Food consumption data were obtained via a food-frequency questionnaire (FFQ) developed by the National Cancer Institute of Canada. The French version of the FFQ used in this study was modified by our unit for French Canadians. The FFQ was designed to collect quantitative information based on food models and qualitative data based on food habits and dietary patterns. It includes questions about >200 different food items and recipes as well as the frequency of consumption and amounts consumed. The FFQ covered a 2-y period before the diagnosis for cases and a corresponding period for the controls. This dietary questionnaire had been assessed for both reproducibility and validity (23).

Food grouping
In total, 985 separate food items, including brand names, were retrieved from the FFQ to estimate daily intakes of specific carotenoids with the use of the US Department of Agriculture–Nutrition Coordinating Center (USDA-NCC) Carotenoid Database (release 1998; Internet: http://www.nal.usda.gov.fnic/foodcomp/Data/car98/). This online database contains data on 218 foods and 6 specific carotenoids; it provides food composition values for specific carotenoids contained in food items assessed by the FFQ. Data on other nutrients, including total carotenoids, individual fatty acids, and total energy, were obtained via the Canadian Nutrient File (release 1991 and 1997). The major food sources of individual carotenoids in the diet of this French Canadian population were carrots, tomatoes and multicomponent foods containing tomatoes (-carotene); carrots and spinach (ß-carotene); orange (ß-cryptoxanthin); tomatoes and tomato products (lycopene); and broccoli and green-leaf vegetables (lutein and zeaxanthin).

Statistical analysis
Food intakes for the cases and controls were converted to specific carotenoid intakes based on the USDA-NCC Carotenoid Database. Median intakes were computed for cases and controls separately. To determine the associations between carotenoid intakes and breast cancer risk, the study subjects were divided into 4 categories according to quartiles of calorie-adjusted carotenoid intakes in the control population. Odds ratios (ORs) and 95% CIs were calculated by using categories of residuals from the regression of carotenoids on total energy intake (24) in unconditional logistic regression models. All analyses were adjusted for age at the first full-term pregnancy, history of breast cancer in first-degree relatives, history of benign breast disease, marital status, number of full-term pregnancies, and total energy intake. History of body weight change since adulthood, body mass index (BMI; in kg/m²) 2 y before the breast cancer diagnosis, physical activity, smoking, fiber and alcohol intakes, oral contraceptive use, and hormone replacement therapy were not significantly different between cases and controls and, thus, were not included in the model.

To evaluate the combined effect of dietary carotenoids and essential fatty acids—namely, linoleic acid, -linolenic acid, arachidonic acid (AA), eicosapentaenoic acid, and docosahexaenoic acid (DHA)—a subgroup analyses based on median splits of these fatty acid intakes in the controls were performed. These analyses focus on individual carotenoid intakes exclusively from diet, rather than on intakes from supplements or multivitamins. It is important to mention that carotenoid supplement use was uncommon in French Canadians at the time the study was conducted. Data analyses were performed separately for pre- and postmenopausal women because some risk factors for breast cancer differ by menopausal status (25) and others are most important in early adult life (26). The combined results for all subjects are presented, unless there were significant differences. All tests of statistical significance were two-sided, and the analyses were conducted with the use of SPSS for WINDOWS (release 10.0.2, 1999; SPSS Inc, Chicago).

	RESULTS

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 
The characteristics of the study population with respect to potential confounders are summarized in Table 1. The mean (±SD) age of the subjects was 55.03 ± 11.87 y for cases and 55.73 ± 12.18 y for the controls (data not shown), with the age distribution of cases and controls being similar. Family history of breast cancer in first-degree relatives as well as family history of benign breast disease in cases and controls indicated that the cases had a significantly higher proportion of first-degree relatives (mother, sisters, and daughters) with breast cancer (P = 0.005) and relatives with benign breast disease (P = 0.001). Cases were older at the time of the first full-term pregnancy than were the controls (P = 0.023), whereas more controls were ever-married than were cases (P = 0.017). A higher proportion of full-term pregnancies was observed in the control group than in the cases (P = 0.002), whereas the use of oral contraceptives and hormone replacement therapy status were not significantly different between the study groups.

Table 2

Table 3

The multivariate-adjusted ORs and 95% CIs for breast cancer risk associated with individual carotenoid intakes according to selected lifestyle factors are shown in Table 4. In the ever-smoker, premenopausal women, a strong positive dose-response relation was noted between -carotene intake and breast cancer risk (OR: 2.40; 95% CI: 0.90, 6.41; P for trend = 0.046). A reverse dose-response relation was found between breast cancer risk and ß-carotene intake (OR: 0.57; 95% CI: 0.26, 1.24; P for trend = 0.050) in premenopausal women who did not receive hormone replacement therapy (P for interaction = 0.04).

	DISCUSSION

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

Our results provide support for effect modification via dietary intake of long-chain fatty acids. To the best of our knowledge, no other studies have addressed the combined effect of total and individual carotenoid intakes and essential fatty acids on the risk of breast cancer, as we did. We observed that total carotenoid intakes were associated with a 1.92-fold greater risk of breast cancer in postmenopausal women with a high AA intake. The biological mechanisms of these effects are unclear, but lipid peroxidation products may play a role (40).

The involvement of AA in eicosanoid synthesis has been well-documented (41). Moreover, AA is very susceptible to lipid peroxidation, and in vitro studies have shown that the secondary products of lipid peroxidation suppress mammary tumorigenic processes by causing an increased accumulation of these cytotoxic or cytostatic products in tumor tissue (42) or by creating intermolecular linkages, intramolecular linkages, or both between amino acid sulfhydryl groups of RNA, DNA, and proteins, which leads to the inactivation or damage of these molecules (43). The addition of high amounts of antioxidants to a medium with a high polyunsaturated fatty acid content considerably reduces the amount of lipid peroxidation products and simultaneously causes a substantial increase in tumor growth (44). With these mechanistic pathways in mind, it is possible that total carotenoid intakes, rather than intakes of any specific carotenoid alone, present the most effective protection for AA against lipid peroxidation in postmenopausal women, because a significant, direct, dose-dependent gradient was found with breast cancer risk in those women with a high AA intake. A decreased risk of breast cancer associated with AA intake in postmenopausal women with a low vitamin E intake and an increased risk in those with a high vitamin E intake were reported by our group in a case-control study (45).

Our findings also provide support for effect modification by smoking and hormone replacement therapy. Smoking increased the breast cancer risk linked with specific carotenoid intakes, although the association was statistically significant only for -carotene. It was shown previously that active and passive smokers are exposed to reactive free radicals present in cigarette smoke (46). Free radicals in cigarette smoke alter the concentrations of most carotenoids, and, compared with nonsmokers, active smokers have circulating concentrations of - and ß-carotene and ß-cryptoxanthin (21) that are >25% lower, even after adjustment for dietary intake of carotenoids (47).

Hormone replacement therapy did not affect circulating concentrations of ß-carotene, the total antioxidant capacity of plasma, or lipid peroxidation in postmenopausal women (48). We found a 43% reduction in premenopausal breast cancer risk associated with ß-carotene in women who did not receive hormone replacement therapy. Although chance could have played a role, further evaluation is needed to clarify the underlying mechanisms of this association. Our results, however, differ from those of Terry et al (18) and Cho et al (35). Terry et al (18) reported no remarkable association between intakes of any specific carotenoids and breast cancer risk in the total group or in subgroups defined by smoking status, BMI, menopausal status, family history of breast cancer, and intakes of total fat, energy, alcohol, or folic acid. Cho et al (35) found that intakes of -carotene and total carotenoids were related to a significant reduction in premenopausal breast cancer risk in smokers but not in nonsmokers.

The major strengths of our investigation are that it focused on French Canadians, a relatively stable and homogeneous North American population with similar lifestyle, food habits and food patterns that distinguish them from their neighbors (20). Its population-based design minimized the potential for biased selection of cases and controls. The participation rates in cases and controls were somewhat similar, and we have no reason to believe, however, that they were influenced differently by past diet. In addition, the cases were interviewed before the final diagnosis and major treatment of cancer.

However, our investigation had some limitations. The 2-y time interval between the interview and the retrospective assessment of diet may have been too long for the study subjects to accurately recall past dietary intakes; therefore, the influence of current diet on the memory of past intakes may have increases the potential for recall bias. However, because this method was used to collect information from both cases and controls, such a bias would not be great. Moreover, because a considerable number of tests was performed, the likelihood that some associations were found by chance could not be excluded completely. In addition to the incompleteness of the USDA-NCC Carotenoid Database, although the FFQ used in this study had been tested for validity and reproducibility for most macronutrients and some essential fatty acids, specific carotenoid intakes determined by the questionnaire had not been validated. However, any bias from these sources may have induced nondifferential misclassification regarding case-control status and reduced the potential to detect some relations. Furthermore, by stratifying for menopausal status, some associations may have been missed because of less-than-optimal sample sizes. These issues may have influenced the results of our study.

In conclusion, we found that a high intake of total carotenoids in combination with a high intake of DHA is associated with a reduced risk of breast cancer in postmenopausal women. As a whole, our data suggest that a diet with a high content of fruit, carotenoid-rich vegetables, and DHA-rich fish may reduce the risk of breast cancer. Additional studies are warranted to examine this finding and to identify the biological mechanisms involved.

	ACKNOWLEDGMENTS

 
We gratefully acknowledge the editorial assistance of Ovid Da Silva.

AN helped with the data entry, analyzed the data, interpreted the analyses, and wrote the manuscript. PG planned and designed the study and helped edit the manuscript. None of the authors had any personal or financial conflicts of interest.

	REFERENCES

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 

1. International Agency for Research on Cancer. Globocan. Internet: http://www-dep.iarc.fr/globocan.html (accessed 22 May 2003).
2. Canadian Cancer Society. Canadian cancer statistics 2002. Toronto: National Cancer Institute of Canada, 2002.
3. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal replacement therapy: collaborative reanalysis of individual data from 51 epidemiological studies of 52,705 women with breast cancer and 100,411 women without breast cancer. Lancet 1997;350:1047–59.[Medline]
4. Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Annu Rev Public Health 1996;17:47–67.[Medline]
5. Hinkula M, Pukkala E, Kyyronen P, Kauppila A. Grand multiparity and the risk of breast cancer: population-based study in Finland. Cancer Causes Control 2001;12:491–500.[Medline]
6. La Vecchia C, Negri E, Boyle P. Reproductive factors and breast cancer: an overview. Soz Praventivmed 1989;34:101–7.[Medline]
7. World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition and cancer prevention: a global perspective. Washington, DC: American Institute for Cancer Research, 1997.
8. Collaborative Group on Hormonal Factors in Breast Cancer. Alcohol, tobacco and breast cancer—collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 2002;87:1234–45.[Medline]
9. Friedenreich CM, Courneya KS, Bryant HE. Influence of physical activity in different age and life periods on the risk of breast cancer. Epidemiology 2001;12:604–12.[Medline]
10. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50,302 women with breast cancer and 96,973 women without the disease. Lancet 2002;360:187–95.[Medline]
11. World Health Organization. IARC handbooks of cancer prevention—carotenoids. Vol 2. Lyon, France: International Agency for Research on Cancer, 1998.
12. Zhang LX, Cooney RV, Bertram JS. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 1991;12:2109–14.[Abstract/Free Full Text]
13. Cooper DA, Eldridge AL, Peters JC. Dietary carotenoids and certain cancers, heart disease, and age-related macular degeneration: a review of recent research. Nutr Rev 1999;57:201–14.[Medline]
14. Le Marchand L, Franke AA, Custer L, Wilkens LR, Cooney RV. Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol. Pharmacogenetics 1997;7:11–9.[Medline]
15. Khachik F, Askin FB, Lai K. Distribution, bioavailability, and metabolism of carotenoids in humans. In: Bidlack WR, Omaye ST, Meskin MS, Jahner D, eds. Phytochemicals: a new paradigm. Lancaster, PA: Technimin Publishing Co, 1998:77–96.
16. Nishino H, Tokuda H, Murakoshi M, et al. Cancer prevention by natural carotenoids. Biofactors 2000;13:89–94.[Medline]
17. Gandini S, Merzenich H, Robertson C, Boyle P. Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer 2000;36:636–46.
18. Terry P, Jain M, Miller AB, Howe GR, Rohan TE. Dietary carotenoids and risk of breast cancer. Am J Clin Nutr 2002;76:883–8.[Abstract/Free Full Text]
19. Ching S, Ingram D, Hahnel R, Beilby J, Rossi E. Serum levels of micronutrients, antioxidants and total antioxidant status predict risk of breast cancer in a case control study. J Nutr 2002;132:303–6.[Abstract/Free Full Text]
20. Ghadirian P, Shatenstein B, Lambert J, et al. Food habits of French Canadians in Montreal, Quebec. J Am Coll Nutr 1995;14:37–45.[Abstract]
21. Alberg AJ. The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 2002;180:121–37.[Medline]
22. Ghadirian P, Lacroix A, Perret C, Maisonneuve P, Boyle P. Sociodemographic characteristics, smoking, medical and family history, and breast cancer. Cancer Prev Detect 1998;22:485–94.
23. Jain M, Howe GR, Rohan T. Dietary assessment in epidemiology: comparison of a food frequency and a diet history questionnaire with a 7-day food record. Am J Epidemiol 1996;143:953–60.[Abstract/Free Full Text]
24. Willett WC, Stampfer MJ. Total energy intake: implications for epidemiologic analysis. Am J Epidemiol 1986;1234:17–27.
25. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997;278:1407–11.[Abstract]
26. Miller AB, Howe GR, Sherman GJ, et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 1989;321:1285–9.[Abstract]
27. Graham S, Zielezny M, Marshall J, et al. Diet in the epidemiology of postmenopausal breast cancer in the New York State cohort. Am J Epidemiol 1992;136:1327–37.[Abstract/Free Full Text]
28. Shibata A, Paganini HA, Ross RK, Henderson BE. Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br J Cancer 1992;66:673–9.[Medline]
29. Hunter DJ, Manson JE, Colditz GA, et al. A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N Engl J Med 1993;329:234–40.[Abstract/Free Full Text]
30. Rohan TE, Howe GR, Friedenreich CM, Jain M, Miller AB. Dietary fiber, vitamins A, C, and E, and risk of breast cancer: a cohort study. Cancer Causes Control 1993;4:29–37.[Medline]
31. Kushi LH, Fee RM, Sellers TA, Zheng W, Folsom AR. Intake of vitamins A, C, and E and postmenopausal breast cancer. The Iowa Women’s Health Study. Am J Epidemiol 1996;144:165–74.[Abstract/Free Full Text]
32. Järvinen R, Knekt P, Seppanen R, Teppo L. Diet and breast cancer risk in a cohort of Finnish women. Cancer Lett 1997;144:251–3.
33. Verhoeven DT, Assen N, Goldbohm RA. Vitamins C and E, retinol, beta-carotene and dietary fibre in relation to breast cancer risk: a prospective cohort study. Br J Cancer 1997;75:149–55.[Medline]
34. Michels KB, Holmberg L, Bergkvist L, Ljung H, Bruce A, Wolk A. Dietary antioxidant vitamins, retinol, and breast cancer incidence in a cohort of Swedish women. Int J Cancer 2001;91:563–7.[Medline]
35. Cho E, Spiegelman D, Hunter D, et al. Premenopausal intakes of vitamins A, C, and E, folates, and carotenoids, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2003;12:713–20.[Abstract/Free Full Text]
36. Zhang S, Hunter DJ, Forman MR, et al. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst 1999;91:547–56.[Abstract/Free Full Text]
37. Freudenhein JL, Marshall JR, Vena JE, et al. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 1996;88:340–8.[Abstract/Free Full Text]
38. Ronco A, De Stefani E, Boffetta P, et al. Vegetables, fruits, and related nutrients and risk of breast cancer: a case-control study in Uruguay. Nutr Cancer 1999;35:111–9.[Medline]
39. Ptischman N, Swanson CA, Coates RJ, et al. Intake of food groups and associated micronutrients in relation to risk of early-stage breast cancer. Int J Cancer 1999;82:315–21.[Medline]
40. Welsch CW. Review of the effects of dietary fat on experimental mammary gland tumorigenesis: role of lipid peroxidation. Free Radic Biol Med 1995;18:757–73.[Medline]
41. Smith WL. The eicosanoids and their biochemical mechanism of action. Biochem Genet 1989;259:315–24.
42. Gonzalez MJ, Schemmel RA, Gray JI, et al. Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice: relationship between carcinoma growth and lipid peroxidation products levels. Carcinogenesis 1991;12:1231–5.[Abstract/Free Full Text]
43. Reiss U, Tappel AL. Fluorescent product formation and changes in structure of DNA reacted with peroxidizing arachidonic acid. Lipids 1973;8:199–202.[Medline]
44. Chajès V, Sattler W, Stranzl A, et al. Influence of n–3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin E. Breast Cancer Res Treat 1995;34:199–212.[Medline]
45. Nkondjock A, Shatenstein B, Ghadirian P. A case-control study of breast cancer and dietary intake of individual fatty acids in Montreal, Canada. Breast 2003;12:131–8.
46. Pryor WA, Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993;686:12–27.
47. Dietrich M, Block G, Norkus EP, et al. Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase -tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nutr 2003;77:160–6.[Abstract/Free Full Text]
48. Bureau I, Laporte F, Favier M, et al. No antioxidant effect of combined HRT on LDL oxidizability and oxidative stress biomarkers in treated post-menopausal women. J Am Coll Nutr 2002;21:333–8.[Abstract/Free Full Text]

This article has been cited by other articles:

				Y. Cui, J. M Shikany, S. Liu, Y. Shagufta, and T. E Rohan Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women's Health Initiative Observational Study Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1009 - 1018. [Abstract] [Full Text] [PDF]

				O. I. Bermudez, J. D. Ribaya-Mercado, S. A. Talegawkar, and K. L. Tucker Hispanic and Non-Hispanic White Elders from Massachusetts Have Different Patterns of Carotenoid Intake and Plasma Concentrations J. Nutr., June 1, 2005; 135(6): 1496 - 1502. [Abstract] [Full Text] [PDF]

				J. D. Ribaya-Mercado and J. B. Blumberg Lutein and Zeaxanthin and Their Potential Roles in Disease Prevention J. Am. Coll. Nutr., December 1, 2004; 23(suppl_6): 567S - 587S. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nkondjock, A. Articles by Ghadirian, P. Search for Related Content PubMed PubMed Citation Articles by Nkondjock, A. Articles by Ghadirian, P. Agricola Articles by Nkondjock, A. Articles by Ghadirian, P.